# A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease

> **NCT01475760** · NA · COMPLETED · sponsor: **Denver Nephrologists, P.C.** · enrollment: 167 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **OTHER:** K2CG chewing gum (20mg chitosan)
- **OTHER:** K2CG chewing gum (60mg chitosan)

## Key facts

- **NCT ID:** NCT01475760
- **Lead sponsor:** Denver Nephrologists, P.C.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 167 (ACTUAL)
- **Last updated:** 2012-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01475760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01475760, "A Study to Evaluate Chitosan Chewing Gum in Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01475760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*